Hello friends - see the link below some really interesting slides by Dr Cortes about CML, results of various studies and also new drugs
https://www.primeoncology.org/app/uploads/hematology-updates-2018-slides...
Hello friends - see the link below some really interesting slides by Dr Cortes about CML, results of various studies and also new drugs
https://www.primeoncology.org/app/uploads/hematology-updates-2018-slides...
Thanks for posting the report from Dr. Cortes.
It looks like his report says that there is 75% relapse when people try cessation from their TKI unless they have maintained a 4.5 level of response for several years. Then the odds get better.
I just looked at information from ASH 2018 and read where they are saying there is about a 40-50% success rate for treatment free remission if a deep response has been consistent for 2 years or more.
Does anyone have insight or information about this? Thanks!
Hi Kali
I agree with your interpretation of the report - it looks like the best chance of success is after maintaining a log 4.5 response for longer than 64 months. This is really interesting to me - I wonder whether people have been trying cessation too early? If I ever get there, I'll be sure to wait 5 years before trying to stop.
The other fascinating take-away I took from reading that presentation is that it looks like a special group of people have been able to take nilotinib only once daily (I think that's what "QD" means) and still maintain a good response? If that's true, it's a game-changer for nilotinib!
Best wishes
Martin
Hi Martin!
i have been in Sprycel for 4.4 years and it has done well too even on reduced dose of 50 mgm. I have maintained undetectable with a couple of very small blips for 3.4 years and prior to that was MMR and lower throughout my first year on the drug. But now with conflicting information about TFR, I am rethinking whether it is time to try going without the drug and do monthly testing or wait until I have 5 years or longer before trying.
I am always cheering on those who are trying TFR and hoping they do well.
I forgot to mention I have now had a really bad pleural effusion with complications and am temporarily off Sprycel and was hoping to see if I could try TFR. I may need to stick with 20 mgm Sprycel to get in more time with undetectable like the Cortes report shows for greater chance of success with TFR.
Friends - see the link below about combination therapy in MD Anderson that showed promise in eradicating the lukemic stem cell (potentially cure CML). This article was posted in 2016 but I wonder why there haven’t been any human trials yet. I recently read another paper published in 2018 saying that a trial of combining 50 mg of Dasatinib with Venetoclax have been planned. We should all email MD Anderson and ask them to progress this trial as soon as possible.
I would be willing to travel to Houston and participate in this trial and even fund part of it if required to move things quickly
https://www.mdanderson.org/newsroom/combination-therapy-.h00-159069501.html
This is really interesting.
I've found this details: https://clinicaltrials.gov/ct2/show/NCT02689440
"Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia"
Actual Study Start Date : February 19, 2016
Estimated Primary Completion Date : February 1, 2019
Estimated Study Completion Date : February 1, 2019
So maybe soon we will have some news on results.
--
Chris